Suppr超能文献

无症状新冠病毒感染背景下的症状性心包积液:一例报告

Symptomatic pericardial effusion in the setting of asymptomatic COVID-19 infection: A case report.

作者信息

Amoozgar Behzad, Kaushal Varun, Mubashar Umair, Sen Shuvendu, Yousaf Shakeel, Yotsuya Matthew

机构信息

Department of Internal Medicine, Jersey Shore University Medical Center, Perth Amboy Division.

University of California, Berkeley, School of Public Health, Berkeley, California.

出版信息

Medicine (Baltimore). 2020 Sep 11;99(37):e22093. doi: 10.1097/MD.0000000000022093.

Abstract

RATIONALE

Infection with the severe acute respiratory coronavirus disease 2019 (COVID-19) has been shown to cause multi-organ involvement including cardiopulmonary serosal layers infection and inflammation. As a result, pericarditis and pericardial effusion may occur with or without COVID-19 related respiratory signs. Due to limitations in sensitivity and specificity of current COVID-19 diagnostic studies, cases that trigger high clinical intuition, even with negative serologic and polymerase chain reaction testing results, may necessitate further diagnostic workup to discover the underlying etiology.

PATIENT CONCERNS

Here we present a rare case of pericardial effusion in the setting of asymptomatic COVID-19 infection manifesting with the chief complaint of chest pain.

DIAGNOSIS

While undergoing diagnostic workup, the patients first 2 sets of COVID 19 reverse transcription-polymerase chain reaction (RT-PCR) were negative while a latter RT-PCR test, as well as serology, were positive, leading to the diagnosis of COVID-19 reinfection or subacute presentation of viral infection with pericardial effusion. Echocardiogram depicted large circumferential pericardial effusion with mildly thickened pericardium.

INTERVENTIONS

The patient underwent pericardial window placement followed by ibuprofen administration and discharged from the hospital.

OUTCOMES

During the follow-up visit patient had no symptoms and echocardiogram demonstrated complete resolution of the effusion.

LESSONS

Due to the possible establishment of pericardial effusions and consecutively tamponade even without any COVID-19 related clinical presentation, it is crucial for clinicians to trust their intuition, conduct the appropriate diagnostic tests, find the underlying diagnosis and prevent the devastating consequences.

摘要

原理

感染严重急性呼吸综合征冠状病毒2019(COVID-19)已被证明可导致多器官受累,包括心肺浆膜层感染和炎症。因此,无论有无COVID-19相关的呼吸道症状,都可能发生心包炎和心包积液。由于目前COVID-19诊断研究的敏感性和特异性存在局限性,即使血清学和聚合酶链反应检测结果为阴性,但引发高度临床怀疑的病例可能需要进一步的诊断检查以发现潜在病因。

患者关注

我们在此报告一例罕见的无症状COVID-19感染合并心包积液的病例,主要表现为胸痛。

诊断

在进行诊断检查时,患者最初的2次COVID-19逆转录-聚合酶链反应(RT-PCR)检测均为阴性,而后来的一次RT-PCR检测以及血清学检测呈阳性,从而诊断为COVID-19再次感染或病毒感染合并心包积液的亚急性表现。超声心动图显示心包大量环形积液,心包轻度增厚。

干预措施

患者接受了心包开窗引流术,随后服用布洛芬,之后出院。

结果

随访期间患者无症状,超声心动图显示积液完全消退。

经验教训

即使没有任何COVID-19相关的临床表现,也可能发生心包积液并继而导致心包填塞,因此临床医生相信自己的直觉、进行适当的诊断检查、找到潜在诊断并预防严重后果至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ae8/7489591/aec2970653c4/medi-99-e22093-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验